Search

Displaying results 5471 - 5480 of 9132 in total
  1. Drug

    Tesnatilimab

    go.drugbank.com/drugs/DB16377
    Investigational

    Tesnatilimab is under investigation in clinical trial NCT04655807 (A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease).

  2. Drug

    NY-ESO-1 peptide vaccine

    go.drugbank.com/drugs/DB17498
    Investigational

    NY-ESO-1 peptide vaccine is an investigational cancer immunotherapy. It contains a peptide derived from the cancer-testis antigen (NY-ESO-1).

  3. Drug

    Tandutinib

    go.drugbank.com/drugs/DB05465
    Investigational

    Approximately 25 to 30 percent of all adult AML patients have a mutation of the FLT3 gene. The use of MLN518 to treat AML has been granted fast-track status by the U.S. Food and Drug Administration. … AML patients with FLT3 mutations experience earlier disease relapse and shorter survival rates compared to patients without these mutations.

  4. Drug

    EMZ702

    go.drugbank.com/drugs/DB05021
    Investigational

    EMZ702, a non-toxic agent that has strong anti-viral synergy with interferon, is an ideal candidate for combination with current standard hepatitis C treatments. … EMZ702 has an excellent safety profile and the combination of EMZ702 with interferon and ribavirin in surrogate models for hepatitis C has demonstrated a two to three fold increase in anti-viral potency

  5. Drug

    Poloxalene

    go.drugbank.com/drugs/DB11451
    InvestigationalVet approved

    Ethylene oxide/propylene oxide copolymer is used as a food additive. It belongs to the family of Epoxides. … These are compounds containing a cyclic ether with three ring atoms (one oxygen and two carbon atoms).

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Sulfaquinoxaline

    go.drugbank.com/drugs/DB11464
    ExperimentalVet approved

    Sulfaquinoxaline is a veterinary medicine which can be given to cattle and sheep to treat coccidiosis.It is available in Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K as

  7. Drug

    Rineterkib

    go.drugbank.com/drugs/DB17560
    Investigational

    Rineterkib is an inhibitor of extracellular signal-regulated kinase (ERK) being investigated in NCT04097821 (A Randomized, Open-label, Phase I/II Open Platform Study Evaluating Safety and Efficacy of Novel

  8. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications.

  9. Drug

    Isoxepac

    go.drugbank.com/drugs/DB19733
    Experimental

    Isoxepac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Isoxepac is a anti-inflammatory agent, ibufenac derivative. … Isoxepac has a monoisotopic molecular weight of 268.07 Da.

  10. Drug

    Lexofenac

    go.drugbank.com/drugs/DB19789
    Experimental

    Lexofenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Lexofenac is a anti-inflammatory agent, ibufenac derivative. … Lexofenac has a monoisotopic molecular weight of 230.09 Da.